188 related articles for article (PubMed ID: 31350342)
1. Active PKG II inhibited the growth and migration of ovarian cancer cells through blocking Raf/MEK and PI3K/Akt signaling pathways.
Wu Y; Cai Q; Li W; Cai Z; Liu Y; Li H; Pang J; Chen Y
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31350342
[TBL] [Abstract][Full Text] [Related]
2. PAK5 Induces EMT and Promotes Cell Migration and Invasion by Activating the PI3K/AKT Pathway in Ovarian Cancer.
Li D; Pan Y; Huang Y; Zhang P; Fang X
Anal Cell Pathol (Amst); 2018; 2018():8073124. PubMed ID: 30245957
[TBL] [Abstract][Full Text] [Related]
3. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway.
Liu J; Hu HB; Liu YM; Li FX; Zhang LP; Liao ZM
Mol Med Rep; 2020 Nov; 22(5):3667-3676. PubMed ID: 33000231
[TBL] [Abstract][Full Text] [Related]
5. MiR-198 inhibits proliferation, invasion and migration of ovarian cancer cells by regulating the PI3K/Akt signaling pathway.
Xiao H; Zheng Y; Chen J; Shen H
Acta Biochim Pol; 2021 Jun; 68(4):673-677. PubMed ID: 34181826
[TBL] [Abstract][Full Text] [Related]
6. Protein Kinases Type II (PKG II) Combined with L-Arginine Significantly Ameliorated Xenograft Tumor Development: Is L-Arginine a Potential Alternative in PKG II Activation?
Wu Y; Liu Y; Cai Z; Qin H; Li H; Su W; Wang Y; Qian H; Jiang L; Wu M; Pang J; Chen Y
Med Sci Monit; 2018 Feb; 24():736-742. PubMed ID: 29401205
[TBL] [Abstract][Full Text] [Related]
7. Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells.
Wu Y; Chen Y; Qu R; Lan T; Sang J
Oncol Rep; 2012 Feb; 27(2):553-8. PubMed ID: 22012247
[TBL] [Abstract][Full Text] [Related]
8. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway.
Shen T; Yang Z; Cheng X; Xiao Y; Yu K; Cai X; Xia C; Li Y
Oncol Rep; 2017 Apr; 37(4):2095-2100. PubMed ID: 28259918
[TBL] [Abstract][Full Text] [Related]
9. PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells.
Jiang L; Lan T; Chen Y; Sang J; Li Y; Wu M; Tao Y; Wang Y; Qian H; Gu L
PLoS One; 2013; 8(4):e61674. PubMed ID: 23613900
[TBL] [Abstract][Full Text] [Related]
10. Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells.
Wu M; Chen Y; Jiang L; Li Y; Lan T; Wang Y; Qian H
Oncol Lett; 2013 Dec; 6(6):1723-1728. PubMed ID: 24273605
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide/cyclic guanosine monophosphate inducers sodium nitroprusside and L-arginine inhibit the proliferation of gastric cancer cells via the activation of type II cyclic guanosine monophosphate-dependent protein kinase.
Yao X; Wu Y; Zhu M; Qian H; Chen Y
Oncol Lett; 2015 Jul; 10(1):479-484. PubMed ID: 26171055
[TBL] [Abstract][Full Text] [Related]
12. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
Ping H; Guo L; Xi J; Wang D
Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
[TBL] [Abstract][Full Text] [Related]
14. Double-Targeted Knockdown of miR-21 and CXCR4 Inhibits Malignant Glioma Progression by Suppression of the PI3K/AKT and Raf/MEK/ERK Pathways.
Liu F; Yang B
Biomed Res Int; 2020; 2020():7930160. PubMed ID: 33123586
[TBL] [Abstract][Full Text] [Related]
15. Wilms' tumor 1 (
Han Y; Song C; Zhang T; Zhou Q; Zhang X; Wang J; Xu B; Zhang X; Liu X; Ying X
Cell Cycle; 2020 Oct; 19(20):2662-2675. PubMed ID: 32892698
[TBL] [Abstract][Full Text] [Related]
16. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
17. Type II cyclic guanosine monophosphate-dependent protein kinase inhibits Rac1 activation in gastric cancer cells.
Wang Y; Chen Y; Wu M; Lan T; Wu Y; Li Y; Qian H
Oncol Lett; 2015 Jul; 10(1):502-508. PubMed ID: 26171059
[TBL] [Abstract][Full Text] [Related]
18. Type II cGMP‑dependent protein kinase inhibits the migration, invasion and proliferation of several types of human cancer cells.
Wu M; Wu Y; Qian H; Tao Y; Pang J; Wang Y; Chen Y
Mol Med Rep; 2017 Oct; 16(4):5729-5737. PubMed ID: 28849123
[TBL] [Abstract][Full Text] [Related]
19. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
20. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.
Liu L; Wu N; Wang Y; Zhang X; Xia B; Tang J; Cai J; Zhao Z; Liao Q; Wang J
J Exp Clin Cancer Res; 2019 Feb; 38(1):106. PubMed ID: 30819230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
